Peter Marks, the venerable head of the FDA’s Center for Biologics Evaluation and Research, has been forced out. In this ...

In a recent BioSpace LinkedIn poll, nearly half of respondents predicted the job market won’t turn around until 2027 or later ...

With President Donald Trump expected to deliver a drug pricing order on Monday that Big Pharma and patient groups alike have ...

Insitro’s layoffs affect about 65 employees as the AI-focused biotech looks to advance its pipeline in metabolic disease and ...

After losing its powerhouse partner, IGM Biosciences closed “most” of its labs and offices and initiated a strategic review ...

The FDA expects to fully integrate its AI approach by June 30, though its different centers have been instructed to start the ...

The missed PDUFA adds to a string of delays at the FDA in recent weeks, including at least two other missed target action ...

The company discontinued development last month of its most mature asset, RLYB212, following disappointing mid-stage ...

Year-over-year BioSpace data show biopharma professionals faced increased competition for fewer employment opportunities ...

The independent experts will meet on May 22 to discuss updates to the COVID-19 vaccine for the upcoming season.

The UCSF professor and frequent YouTube poster has criticized COVID-19 vaccine mandates as well as the accelerated approval ...

In this episode of Denatured BioSpace's head of insights Lori Ellis discusses the public health consequences of vaccine ...